NCT05307744View on ClinicalTrials.gov

Effects of Lactobacillus Plantarum PS128 in Children With ASD

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2026

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

PS128

Each PS128 capsule contained \>3 × 10\^10 colony forming units (CFU) with microcrystalline cellulose and weights 425 ± 25 mg.

OTHER

Placebo

The placebo capsules only contained 425 ± 25 mg microcrystalline cellulose.

Trial Locations (1)

Unknown

RECRUITING

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
collaborator

Bened Biomedical Co., Ltd.

INDUSTRY

lead

Chang Gung Memorial Hospital

OTHER

NCT05307744 - Effects of Lactobacillus Plantarum PS128 in Children With ASD | Biotech Hunter | Biotech Hunter